Sanofi

Sanofi

Sanofi

Overview
Date Founded

2004

Headquarters

54, rue La Boétie,Paris, Ile-de-France 75008

Type of Company

Public

Employees (Worldwide)

107K

Industries

Pharmaceuticals
Wholesale: Consumer Non-Durables/Sundries
Hospitals & Patient Services
Medical Support Services

Company Description

Sanofi, a diversified global healthcare leader, discovers, develops, and distributes therapeutic solutions to improve the lives of everyone. We work to prevent and treat the diseases that we know of today, as well as those we may face tomorrow. With nearly 100,000 dedicated professionals in more than 100 countries, Sanofi is devoted to advancing healthcare around the world. Sanofi US, with headquarters in Bridgewater, New Jersey, along with our vaccines division, Sanofi Pasteur, employs more than 11,400 professionals throughout the country. At Sanofi, we work for what really matters: health

Website
Executives & Employees

Director & Chief Executive Officer

Executive Vice President & Chief Financial Officer

Executive Vice President, Legal Affairs & General Counsel

Chief Regulatory Officer

Executive Vice President & General Manager, Diabetes & Cardiovascular

Executive Vice President & General Manager, Sanofi Pasteur

President, Merial North America

Executive Vice President & Head-Business Transformation

Head of IR North America & Asia

Head-Global Research & Development

Board of Directors

Founder at Weinberg Capital Partners SAS

Director & Chief Executive Officer at Sanofi

Chairman at Truffle Capital

Vice Chairman & Chief Executive Officer at Dassault Systèmes SA

Partner at Morgan, Lewis & Bockius LLP

Former Executive Vice President Chief Financial Officer at L'Oréal SA

Investigator at Howard Hughes Medical Institute, Inc.

Deputy Chief Executive Officer, Finance & Legal Affairs at Schneider Electric SE

Paths to Sanofi
Potential Connections via
Relationship Science
You
Sanofi
Owners & Shareholders
Details Hidden

Dodge & Cox manages diversified equity, fixed-income and balanced separate accounts and mutual funds for individuals and institutions. Individual security selection is based on the relationship of fundamentals to valuation. The firm maintains a long-term investment horizon and an employs an investment approach that emphasizes the evaluation of risk relative to opportunity. The firm adheres to a strict price discipline. Dodge & Cox's Stock Fund seeks long-term growth of principal and income. The fund's secondary objective is the generation of reasonable current income. The fund invests primarily in a diversified portfolio of the common stocks of companies that appear to be temporarily undervalued by the stock market but have a favorable outlook for long-term growth.Dodge & Cox's Global Stock Fund seeks long-term growth of principal and income through investments primarily in a diversified portfolio of equity securities issued by companies from at least 3 different countries, including emerging markets. The fund invests mainly in medium-to-large sized, well-established companies. The fund is not required to allocate investments to particular companies in set percentages. Typically, 40% of the fund's total assets are invested in the securities of non-US companies.The firm's International Stock Fund seeks long-term growth of principal and income through investments primarily in a diversified portfolio of equity securities issued by non-US companies from at least 3 different foreign countries, including emerging markets. The fund focuses on countries whose economic and political systems appear more stable and are believed to provide some protection to foreign shareholders. The fund invests mainly in medium-to-large sized, well-established companies that appear to be temporarily undervalued by the stock market but have a favorable outlook for long-term growth.Dodge & Cox's Balanced Fund seeks regular income, conservation of principal and an opportunity for long-term growth of principal and income through investments in a diversified portfolio of common stocks, preferred stocks and fixed-income securities. The fund invests in companies that appear to be temporarily undervalued by the stock market but have a favorable outlook for long-term growth. The fund typically holds no more than 75% of its total assets in stocks. The fund's invests in investment-grade fixed-income securities including US government obligations, MBS, ABS, corporate bonds, collateralized mortgage obligations and others. To a lesser extent, the fund may also invest in below investment-grade fixed income securities.The firm's Income Fund seeks a high and stable rate of current income, consistent with long-term preservation of capital with the secondary objective of capital appreciation. The fund invests primarily in a diversified portfolio of high-quality bonds and other fixed-income securities including US government obligations, MBS, ABS, corporate bonds and collateralized mortgage obligations.

Details Hidden

Amundi-IM is an active manager which invests through funds in all asset classes and main currencies. They are market leaders in Euro fixed-income, global fixed-income, money market and credit activities with a solid presence in European equities and strong niche areas of expertise in Japanese and emerging market equities.The firm believes that overall analysis of a company, including economic, social and environmental aspects, allows for better assessment of the risks and opportunities that may affect its long-term valuation.

Details Hidden

Franklin Advisers provides advisory services to a range of products and separate accounts which utilize various investment strategies including equity, fixed income, core/hybrid and multi-asset.The Franklin US Growth Equity strategies seek to provide long-term capital appreciation by investing in companies meeting the firm's criteria for growth, quality and valuation. Franklin Advisers utilizes bottom-up, fundamental analysis and focuses on high quality companies that can produce sustainable earnings and cash flow growth. They look for companies with potential for sustainable growth that is not already reflected in current stock prices. Strategies may focus on companies with a specific market-cap or on companies across all market-caps.Franklin Advisers offers actively managed fixed income strategies that emphasize rotation among different types of debt on a relative value basis; specific security selection; quantitative analysis of each security and the portfolio as a whole; and intensive credit analysis and review. Portfolios generally focus on one or more of the following: taxable and tax-exempt money market instruments; tax-exempt and taxable municipal securities; global fixed income securities; and taxable fixed income debt securities.The Franklin Core/Hybrid investment team employs bottom-up, fundamental analysis and seeks to exploit a fundamental view that differs from the market consensus regarding growth potential or valuation. They look for opportunities across asset classes including equities, fixed income and convertibles. The team also seeks to take advantage of price dislocations that result from the market's short-term focus.Franklin Advisers offers multi-asset strategies that utilize a combination of strategic, tactical and mandate research capabilities including global tactical asset allocation strategies, long-term strategic advisory mandates, packaged target date/target risk strategies, static allocation strategies and real return strategies.

Recent Transactions
Details Hidden

Recipharm AB purchases Sanofi /CMO Business from Sanofi

Details Hidden

Sanofi purchases Ablynx NV

Details Hidden

Advent International Corp. purchases Sanofi /European Generic drugs Division from Sanofi

Transaction Advisors
Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Legal Advisor

Advised onSanofi purchases TargeGen, Inc.

Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Legal Advisor

Advised onSanofi purchases TargeGen, Inc.

Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Legal Advisor

Advised onSanofi purchases Sanofi Genzyme

Advisors & Consultants
Legal Advisor

Partner at Jones Day

Legal Advisor

Partner at Jones Day

Legal Advisor

Co-Chair, Antitrust & Competition Practice Group at Gibson, Dunn & Crutcher LLP

Clients

Universal Robina Corp. is engaged in the manufacture and distribution of consumer food products. It operates through the following segments: Branded Consumer Foods, Agro-Industrial Products, Commodity Food Products, and Corporate Business. The Branded Consumer Foods segment manufactures and distributes salty snacks, chocolates, candies, biscuits, bakery products, beverages, instant noodles, pasta and tomato-based products. The Agro-Industrial Products segment produces and distributes an animal health products, animal feeds, glucose and soya bean products; and operates hog and poultry farm. The Commodity Food Products segment refines sugar and flour as well as manufactures pasta. Its products include savory snacks, biscuits, cakes, candies, chocolates, ready-to-drink tea and coffee; juices, bottled water, energy drinks, pure and blended coffee; creamer, instant coffee and chocolate mixes; pouch and cup noodles; canned beans, sauces and tomato paste. The Corporate Business segment engages in bonds and securities investment and fund sourcing activities. The company was founded by John L. Gokongwei Jr. on September 28, 1954 and is headquartered in Quezon City, Philippines.

Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies. The Prescription Pharmaceutical segment handles R&D, manufacturing, and sale of ethical drugs. It also provides the manufacture and sale of prescription pharmaceuticals; and businesses incidental or related thereto. The company was founded on October 3, 2011 and is headquartered in Tokyo, Japan.

Chongqing Zhifei Biological Products Co., Ltd. engages in the wholesale of biological products and vaccines. Its main products are meningococcal group A&C conjugate vaccine, meningococcal polysaccharide vaccine, mycobacterium vaccae, Haemophilus Influenzae type b conjugate vaccine, and freeze-dried live attenuated hepatitis A vaccine. Its other activities are biotechnology research, development, and consulting; import and export, and storage services. The company was founded on July 20, 1995 and is headquartered in Chongqing, China.

Key Stats and Financials As of 2017
Market Capitalization
$89.5B
Total Enterprise Value
$96.3B
Earnings Per Share
$3.02
Revenue
$35.1B
Net Profit
$3.79B
EBITDA
$9.17B
EBITDAMargin
26.15%
Total Debt
$15.6B
Total Equity
$58.3B
Enterprise Value Sales
2.75x
Enterprise Value EBITDAOperating
10.51x
TEVNet Income
25.41x
Debt TEV
0.16x
Three Year Compounded Annual Growth Rate Of Revenue
1.25%
Five Year Compounded Annual Growth Rate Of Revenue
0.06%
Investments
Details Hidden

NJOY LLC manufactures and distributes electronic cigarettes. Its products include kings, express starter kits, cartridge refills and onejoy disposable ecigs. The company offers a variety of rechargeable and non-rechargeable electronic cigarette products made for adult smokers. It provides nicotine and rich tobacco and menthol flavor without smoke or odor. NJOY was founded by Mark H. Weiss and Craig Weiss in 2006 and is headquartered in Scottsdale, AZ.

Details Hidden
Details Hidden

Thermalin Diabetes LLC develops insulin treatments for patients with diabetes. It offers ultra-rapid acting insulins that are taken before meals to dampen glucose spikes; and long acting insulins for promoting non-mealtime basal level in diabetes patients. The company was founded by Michael Weiss and Richard Berenson in 2009 and is headquartered in Cleveland, OH.

Investors
Details Hidden

Founder at Icahn Enterprises LP

Suppliers
Publicis Groupe SA Hospitals & Patient Services | Paris, IF

Publicis Groupe SA engages in the advertising industry. Its services include customer relationship management, direct marketing, sales promotion, events management, public relations, corporate, multicultural and financial communications. The company was founded by Marcel Bleustein-Blanchet in 1926 and is headquartered in Paris, France.

Sodexo SA Other Business & Consulting Services | Issy-les-Moulineaux, IF

Sodexo SA engages in the provision of on-site services, benefits and rewards services, and personal and home care services. It offers integrated solutions which cover a variety of working and living environments and are available in client segments which include corporate, health care, education, defense, remote sites, justice services, seniors, and sports and leisure. Sodexo was founded by Pierre Bellon in 1966 and is headquartered in Issy-les-Moulineaux, France.

Neurones SA Internet Software & Services | Nanterre, IF

Neurones SA engages in providing management consulting and information technology services. Its services include infrastructure, application and management consultations. The company operates business through its segments: Infrastructure Services, Application Services and Consulting. The Infrastructure Services segment engages in the systems and networks, service desk, workstation outsourcing, server and application outsourcing in cloud, computing mode, IT security, IT operations, IT service management and IT governance. The Application Services segment engages in the web and decision support BI, IT consulting for finance, SAP, content management and business process management, IT training and change management. The Consulting segment engages in the management and organization consulting. The company was founded on December 5, 1984 and is headquartered in Nanterre, France.

Competitors
Merck & Co., Inc. Pharmaceuticals - Kenilworth, NJ

Merck & Co., Inc. , d.b.a. Merck Sharp & Dohme, MSD outside the United States and Canada, is an American pharmaceutical company and is one of the largest pharmaceutical companies in the world.

Johnson & Johnson Pharmaceuticals - New Brunswick, New Jersey

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Pfizer, Inc. Pharmaceuticals - WASHINGTON, DC

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.